Cargando…

Correlation between Clinical Characteristics and Antibody Levels in COVID-19 Convalescent Plasma Donor Candidates

COVID-19 convalescent plasma (CCP) with high neutralizing antibodies has been suggested in preventing disease progression in COVID-19. In this study, we investigated the relationship between clinical donor characteristics and neutralizing anti-SARS-CoV-2 antibodies in CCP donors. COVID-19 convalesce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uzun, Günalp, Müller, Rebecca, Althaus, Karina, Becker, Matthias, Marsall, Patrick, Junker, Daniel, Nowak-Harnau, Stefanie, Schneiderhan-Marra, Nicole, Klüter, Harald, Schrezenmeier, Hubert, Bugert, Peter, Bakchoul, Tamam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301943/ https://www.ncbi.nlm.nih.gov/pubmed/37376656 http://dx.doi.org/10.3390/v15061357

Ejemplares similares

Increased plasma level of soluble P-selectin in non-hospitalized COVID-19 convalescent donors
por: Müller, Rebecca, et al.
Publicado: (2022)

No Correlation between Anti-PF4 and Anti–SARS-CoV-2 Antibodies after ChAdOx1 nCoV-19 Vaccination
por: Uzun, Günalp, et al.
Publicado: (2021)

The interaction between anti-PF4 antibodies and anticoagulants in vaccine-induced thrombotic thrombocytopenia
por: Singh, Anurag, et al.
Publicado: (2022)

Vaccine Side Effects in Health Care Workers after Vaccination against SARS-CoV-2: Data from TüSeRe:exact Study
por: Bareiß, Alan, et al.
Publicado: (2022)

Primary Immune Thrombocytopenia: Novel Insights into Pathophysiology and Disease Management
por: Singh, Anurag, et al.
Publicado: (2021)

Platelet phosphatidylserine is the critical mediator of thrombosis in heparin-induced thrombocytopenia
por: Zlamal, Jan, et al.
Publicado: (2023)

Inhibition of GPIb-α-mediated apoptosis signaling enables cold storage of platelets
por: Marini, Irene, et al.
Publicado: (2023)

Immune-Mediated Platelet Activation in COVID-19 and Vaccine-Induced Immune Thrombotic Thrombocytopenia
por: Uzun, Günalp, et al.
Publicado: (2022)

Treatment of drug-induced immune thrombocytopenias
por: Marini, Irene, et al.
Publicado: (2022)

Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies
por: Körper, Sixten, et al.
Publicado: (2021)

Platelet-neutrophil interaction in COVID-19 and vaccine-induced thrombotic thrombocytopenia
por: Hirsch, Johannes, et al.
Publicado: (2023)

Antibody‐mediated platelet activation in COVID‐19: A coincidence or a new mechanism of the dysregulated coagulation system?
por: Althaus, Karina, et al.
Publicado: (2021)

Cold storage of platelets in additive solution: the impact of residual plasma in apheresis platelet concentrates
por: Marini, Irene, et al.
Publicado: (2019)

Antibody‐mediated procoagulant platelet formation in COVID‐19 is AKT dependent
por: Pelzl, Lisann, et al.
Publicado: (2022)

Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants
por: Junker, Daniel, et al.
Publicado: (2022)

Autoantibody-mediated desialylation impairs human thrombopoiesis and platelet lifespan
por: Marini, Irene, et al.
Publicado: (2019)

Autoimmune Heparin-Induced Thrombocytopenia after Transcatheter Aortic Valve Implantation: Successful Treatment with Adjunct High-Dose Intravenous Immunoglobulin
por: Bakchoul, Tamam, et al.
Publicado: (2019)

Use of Targeted High-Throughput Sequencing for Genetic Classification of Patients with Bleeding Diathesis and Suspected Platelet Disorder
por: Andres, Oliver, et al.
Publicado: (2018)

Evaluation of Single Nucleotide Variants in Intron 1 of the ABO Gene as Diagnostic Markers for the A(1) Blood Group
por: Bugert, Peter, et al.
Publicado: (2023)

One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients
por: Körper, Sixten, et al.
Publicado: (2022)

The use of IV immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopenia
por: Uzun, Günalp, et al.
Publicado: (2021)

Low-dose alemtuzumab induction in a tailored immunosuppression protocol for sensitized kidney transplant recipients
por: Guthoff, Martina, et al.
Publicado: (2020)

Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
por: Becker, Matthias, et al.
Publicado: (2021)

Optimized PCR with sequence specific primers (PCR-SSP) for fast and efficient determination of Interleukin-6 Promoter (-597/-572/-174)Haplotypes
por: Müller-Steinhardt, Michael, et al.
Publicado: (2009)

Hypofibrinolysis in pediatric patients with veno-occlusive disease in hematopoietic stem cell transplantation
por: Schneider, Veronika, et al.
Publicado: (2023)

Fibrinolysis shut down in COVID-19 patients: Report on two severe cases with potential diagnostic and clinical relevance
por: Bakchoul, Tamam, et al.
Publicado: (2020)

Uterine allograft removal by total laparoscopic hysterectomy after successful cesarean delivery in a living-donor uterus recipient with uterovaginal agenesis (MRKHS)
por: Brucker, Sara Yvonne, et al.
Publicado: (2022)

Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia
por: Althaus, Karina, et al.
Publicado: (2021)

Vaccinations and ITP: keep on track(ing)
por: Bakchoul, Tamam, et al.
Publicado: (2022)

SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against Omicron subvariants BA.1, BA.2 and BA.5 and can be predicted by anti-S antibody concentrations in serological assays
por: Seidel, Alina, et al.
Publicado: (2023)

Analytical performance of 17 commercially available point-of-care tests for CRP to support patient management at lower levels of the health system
por: Calarco, Serafina, et al.
Publicado: (2023)

Antibody-induced procoagulant platelets in severe COVID-19 infection
por: Althaus, Karina, et al.
Publicado: (2021)

Can Henna Prevent Ulceration in Diabetic Feet at High Risk?
por: Mutluoğlu, Mesut, et al.
Publicado: (2009)

Antibody Response against SARS-CoV-2 and Seasonal Coronaviruses in Nonhospitalized COVID-19 Patients
por: Ruetalo, Natalia, et al.
Publicado: (2021)

COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants
por: Junker, Daniel, et al.
Publicado: (2022)

Predicting Successful Hematopoietic Stem Cell Collection in Healthy Allogeneic Donors
por: Kayser, Sabine, et al.
Publicado: (2023)

Appropriate selection of convalescent plasma donors for COVID-19
por: Tedder, Richard S, et al.
Publicado: (2021)

Evaluation of SARS‐CoV‐2 antibody titers and potency for convalescent plasma donation: a brief commentary
por: Wouters, Elise, et al.
Publicado: (2020)

Motivation, blood donor satisfaction and intention to return during the COVID‐19 pandemic
por: Weidmann, Christian, et al.
Publicado: (2021)

Recruitment Strategy for Potential COVID-19 Convalescent Plasma Donors
por: Andersen, Kylie J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8ugla2u75rhl0sqscgde915mtn